These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28885772)

  • 21. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients.
    Zeng X; Li XX; Shi PM; Zhang YY; Song Y; Liu Q; Wei L; Bajaj JS; Zhu YH; Li Y; Gu Y; Xie WF; Liu YL
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1843-1850. PubMed ID: 30861191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EncephalApp stroop test versus electronic number connection test-A for screening minimal hepatic encephalopathy in patients with liver cirrhosis: a comparative study.
    Luo M; Hu FR; Wang PD; Yao L; Hu SJ; Bai FH
    Scand J Gastroenterol; 2022 Sep; 57(9):1066-1069. PubMed ID: 35348416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis.
    Zarantonello L; Turco M; Formentin C; Izquierdo-Altarejos P; Vuerich A; Barcenas Jimenez MJ; Montoliu C; Felipo V; Angeli P; Amodio P; Montagnese S
    Liver Int; 2019 May; 39(5):861-870. PubMed ID: 30658006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Chen HJ; Shi HB; Jiang LF; Li L; Chen R
    Eur Radiol; 2018 Jan; 28(1):85-95. PubMed ID: 28667481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy.
    Zeng X; Zhang LY; Liu Q; Lu CH; Wei J; Shi ZW; Huang WR; Qu LH; Xu F; Wang XH; Shi PM; Tan Y; Tan W; Yuan ZL; Xia CY; Liu YL; Xie WF
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1618-1625.e7. PubMed ID: 31712074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
    Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renormalization of Thalamic Sub-Regional Functional Connectivity Contributes to Improvement of Cognitive Function after Liver Transplantation in Cirrhotic Patients with Overt Hepatic Encephalopathy.
    Cheng Y; Li JL; Zhou JM; Zhang GY; Shen W; Zhang XD
    Korean J Radiol; 2021 Dec; 22(12):2052-2061. PubMed ID: 34564958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USE OF THE STROOP ENCEPHALAPP FOR COVERT HEPATIC ENCEPHALOPATHY SCREENING IN CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL.
    Machado JÚnior PAB; Ziliotto RD; Ferreira APVN; Buson TM; Couto CMD; Pissaia Junior A
    Arq Gastroenterol; 2020; 57(4):399-403. PubMed ID: 33237215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Acharya C; Nadhem O; Shaw J; Hassouneh R; Fagan A; McGeorge S; Sterling RK; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles HS; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Am J Gastroenterol; 2021 Dec; 116(12):2385-2389. PubMed ID: 34140445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromarkers from Whole-Brain Functional Connectivity Reveal the Cognitive Recovery Scheme for Overt Hepatic Encephalopathy after Liver Transplantation.
    Cheng Y; Shen W; Xu J; Amey RC; Huang LX; Zhang XD; Li JL; Akhavan C; Duffy BA; Simon JP; Jiang W; Liu M; Kim H
    eNeuro; 2021; 8(4):. PubMed ID: 34376523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dynamic nomogram to predict transplant-free mortality in patients with hepatitis B-related cirrhosis and overt hepatic encephalopathy.
    Shi K; Huang Y; Zhang Q; Ran C; Hou J; Zhang Y; Bi Y; Wang X
    Int Immunopharmacol; 2022 Jul; 108():108879. PubMed ID: 35623289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study.
    Ehrenbauer AF; Egge JFM; Gabriel MM; Tiede A; Dirks M; Witt J; Wedemeyer H; Maasoumy B; Weissenborn K
    Hepatology; 2024 Aug; 80(2):389-402. PubMed ID: 38349709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive function in patients with liver cirrhosis without overt hepatic encephalopathy: assessment using an automated neuropsychological test battery.
    Sunmonu TA; Adekanle O; Komolafe MA; Ndububa DA
    Arab J Gastroenterol; 2012 Mar; 13(1):4-8. PubMed ID: 22560817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Minimal Hepatic Encephalopathy with Brain MRI and EncephalApp Stroop Test.
    Lupescu IC; Iacob S; Lupescu IG; Pietrareanu C; Gheorghe L
    Maedica (Bucur); 2023 Mar; 18(1):4-11. PubMed ID: 37266463
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
    Garcia-Martinez R; Rovira A; Alonso J; Jacas C; Simón-Talero M; Chavarria L; Vargas V; Córdoba J
    Liver Transpl; 2011 Jan; 17(1):38-46. PubMed ID: 21254343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.